Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune (Idiopathic) Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05281068
What this trial is testing

The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
ITPImmune Thrombocytopenia
Peking University People's Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06721013
What this trial is testing

Pirtobrutinib in Participants With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Eli Lilly and Company 68
Not applicableUnknownNCT01970189
What this trial is testing

The International ITP Registry

Who this might be right for
Thrombocytopenia
South Eastern Sydney Local Health District 500
Testing effectiveness (Phase 2)Looking for participantsNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Testing effectiveness (Phase 2)Study completedNCT00111475
What this trial is testing

Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Amgen 45
Large-scale testing (Phase 3)WithdrawnNCT01734057
What this trial is testing

Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University
Large-scale testing (Phase 3)WithdrawnNCT01609452
What this trial is testing

MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP

Who this might be right for
Immune Thrombocytopenic PurpuraIdiopathic Thrombocytopenic Purpura
Anthera Pharmaceuticals
Not applicableWithdrawnNCT01864512
What this trial is testing

Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment

Who this might be right for
Immune Thrombocytopenia
Shandong University
Early research (Phase 1)Ended earlyNCT00571467
What this trial is testing

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Protalex, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00005652
What this trial is testing

Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
University of Alabama at Birmingham 20
Not applicableStudy completedNCT03412188
What this trial is testing

The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Nayera Hazaa Elsherif 36
Testing effectiveness (Phase 2)UnknownNCT02757196
What this trial is testing

Treatment of ITP With Rituximab and / or Accutane

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 112
Large-scale testing (Phase 3)Study completedNCT00426270
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Who this might be right for
Immune Thrombocytopenic Purpura
Octapharma 116
Testing effectiveness (Phase 2)Ended earlyNCT05502783
What this trial is testing

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI) 1
Early research (Phase 1)Looking for participantsNCT06943937
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT01610180
What this trial is testing

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraAutoimmune Thrombocytopenia+2 more
Fondazione Progetto Ematologia 18
Post-approval studies (Phase 4)Study completedNCT04638829
What this trial is testing

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 60
Early research (Phase 1)Not Yet RecruitingNCT07765966
What this trial is testing

Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias

Who this might be right for
Immune Thrombocytopenia (ITP)
RiboX Therapeutics Ltd. 27
Not applicableWithdrawnNCT01443351
What this trial is testing

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Zealand University Hospital
Testing effectiveness (Phase 2)UnknownNCT03013114
What this trial is testing

A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shandong University 20
Next Page